Renalytix plc (LSE: RENX) (OTCQB: RNLXY), today announced an agreement with Tempus AI, Inc. (NASDAQ: TEM) to make ...

GLP-1 receptor agonists may reduce the likelihood of mortality and increase odds for transplant wait-listing for patients ...

When you have uncontrolled blood sugar, it can affect your health in several ways. High blood sugar levels damage different ...

The blockbuster weight loss drug semaglutide can cut the progression of diabetic kidney disease, according to its manufacturer Novo Nordisk, adding to growing evidence that the medication has ...

Severe hypoglycemia is linked to a higher rate of retinopathy in patients with type 2 diabetes and proliferative disease in ...

Please provide your email address to receive an email when new articles are posted on . The cost of care increased as the disease progressed. Mean per-patient per-month costs increased from $1,597 in ...

Weekly injections of semaglutide medications like Ozempic significantly reduce the risk of serious kidney outcomes, major cardiovascular events and death among people who have type 2 diabetes and ...

Kidney disease is becoming a growing problem in developing countries, caused by an explosion in cases of diabetes and high blood pressure, experts say. As developing countries become increasingly ...